Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CORT
CORT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CORT News
Kuehn Law Investigates Corcept Executives for Fiduciary Breach
2d ago
Globenewswire
Corcept Therapeutics Resubmits NDA for Relacorilant
3d ago
seekingalpha
Corcept Resubmits NDA for Relacorilant to Treat Cushing's Syndrome
3d ago
Newsfilter
New Data Reveals Korlym's Potential in Diabetes Treatment
Jun 06 2026
Newsfilter
New Data Reveals Korlym's Potential in Diabetes Treatment
Jun 06 2026
Yahoo Finance
Corcept Presents New Survival Data for Lifyorli
May 29 2026
Newsfilter
Corcept Plans to Resubmit New Drug Application for Cushing's Syndrome
May 27 2026
stocktwits
Corcept Therapeutics Stock Rises 7% After UBS Upgrade to Buy
May 13 2026
seekingalpha
Wall Street's Latest Ratings Overview
May 13 2026
CNBC
John Hussman's Q1 2026 Investment Moves Revealed
May 11 2026
Yahoo Finance
Corcept Therapeutics Reports Q1 2026 Earnings and Raises Revenue Guidance
May 01 2026
seekingalpha
CORCEPT THERAPEUTICS INC ANTICIPATES PROFITABILITY BY Q2 2026
Apr 30 2026
moomoo
Corcept Lawsuit Reminder for Investors
Apr 21 2026
PRnewswire
Corcept Presents New Data on Lifyorli at ASCO 2026
Apr 21 2026
Newsfilter
Corcept Therapeutics Class Action Reminder for Investors
Apr 21 2026
Globenewswire
Corcept Therapeutics Shareholder Lawsuit Reminder
Apr 21 2026
PRnewswire
Show More News
